128 related articles for article (PubMed ID: 21837765)
1. Increased nuchal translucency, normal karyotype and infant development.
Miltoft CB; Ekelund CK; Hansen BM; Lando A; Petersen OB; Skovbo P; Jørgensen FS; Sperling L; Zingenberg H; Nikkila A; Shalmi AC; Stornes I; Ersbak V; Tabor A
Ultrasound Obstet Gynecol; 2012 Jan; 39(1):28-33. PubMed ID: 21837765
[TBL] [Abstract][Full Text] [Related]
2. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age.
Mula R; Goncé A; Bennásar M; Arigita M; Meler E; Nadal A; Sánchez A; Botet F; Borrell A
Ultrasound Obstet Gynecol; 2012 Jan; 39(1):34-41. PubMed ID: 21837766
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of children born after a first-trimester measurement of nuchal translucency at the 99th percentile or greater with normal karyotype: a prospective study.
Senat MV; Bussières L; Couderc S; Roume J; Rozenberg P; Bouyer J; Ville Y
Am J Obstet Gynecol; 2007 Jan; 196(1):53.e1-6. PubMed ID: 17240232
[TBL] [Abstract][Full Text] [Related]
4. [Long term follow-up of children with increased nuchal translucency and normal karyotype on first trimester sonography].
Jenewein N; Scheier M; Kiechl-Kohlendorfer U
Klin Padiatr; 2009; 221(1):14-8. PubMed ID: 18989839
[TBL] [Abstract][Full Text] [Related]
5. Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency.
Timmerman E; Pajkrt E; Bilardo CM
Ultrasound Obstet Gynecol; 2009 Oct; 34(4):373-8. PubMed ID: 19618399
[TBL] [Abstract][Full Text] [Related]
6. [Increased nuchal translucency with normal karyotype].
Senat MV; Frydman R
Gynecol Obstet Fertil; 2007 Jun; 35(6):507-15. PubMed ID: 17521948
[TBL] [Abstract][Full Text] [Related]
7. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population.
Westin M; Saltvedt S; Almström H; Grunewald C; Valentin L
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):150-8. PubMed ID: 17211897
[TBL] [Abstract][Full Text] [Related]
8. [Long-term follow-up of children with prenatally found increased nuchal translucency and normal karyotype].
Kornacki J; Ziółkowska K; Ignaszak N; Skrzypczak J
Ginekol Pol; 2015 Jan; 86(1):21-5. PubMed ID: 25775871
[TBL] [Abstract][Full Text] [Related]
9. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
Bronshtein M; Zimmer EZ; Blazer S
Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
[TBL] [Abstract][Full Text] [Related]
10. Increased nuchal translucency with normal karyotype: a follow-up study of 100 cases supplemented with CGH and MLPA analyses.
Schou KV; Kirchhoff M; Nygaard U; Jørgensen C; Sundberg K
Ultrasound Obstet Gynecol; 2009 Dec; 34(6):618-22. PubMed ID: 19953565
[TBL] [Abstract][Full Text] [Related]
11. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes.
Krantz D; Goetzl L; Simpson JL; Thom E; Zachary J; Hallahan TW; Silver R; Pergament E; Platt LD; Filkins K; Johnson A; Mahoney M; Hogge WA; Wilson RD; Mohide P; Hershey D; Wapner R;
Am J Obstet Gynecol; 2004 Oct; 191(4):1452-8. PubMed ID: 15507982
[TBL] [Abstract][Full Text] [Related]
12. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome for children born after a first-trimester measurement of increased nuchal translucency with a normal karyotype: a retrospective analysis.
Axt-Fliedner R; Hartge D; Chiriac A; Krapp M; Berg C; Geipel A; Germer U; Gembruch U
Ultraschall Med; 2009 Dec; 30(6):558-63. PubMed ID: 19137496
[TBL] [Abstract][Full Text] [Related]
14. Nuchal translucency thickness in euploid fetuses: is two millimeters too risky?
Fink M; Sheiner E; Sheizaf B; Hershkovitz R; Bashiri A; Mazor M; Wiznitzer A
Am J Perinatol; 2009 Apr; 26(4):303-7. PubMed ID: 19031359
[TBL] [Abstract][Full Text] [Related]
15. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
16. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
Dugoff L; Hobbins JC; Malone FD; Porter TF; Luthy D; Comstock CH; Hankins G; Berkowitz RL; Merkatz I; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Vidaver J; D'Alton ME
Am J Obstet Gynecol; 2004 Oct; 191(4):1446-51. PubMed ID: 15507981
[TBL] [Abstract][Full Text] [Related]
17. [Perinatal and pediatric follow up of children with increased nuchal translucency and normal karyotype].
Vieira LA; Silva SV; de Faria RB; Lippi UG; Lopes RG
Rev Bras Ginecol Obstet; 2013 Jun; 35(6):274-80. PubMed ID: 23929201
[TBL] [Abstract][Full Text] [Related]
18. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
Sepulveda W; Wong AE; Dezerega V
Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
[TBL] [Abstract][Full Text] [Related]
19. Neurodevelopmental outcome at 2 years of corrected age in fetuses with increased nuchal translucency thickness and normal karyotype compared with matched controls.
Buffin R; Fichez A; Decullier E; Roux A; Bin S; Combourieu D; Pastor-Diez B; Huissoud C; Picaud JC;
Ultrasound Obstet Gynecol; 2021 May; 57(5):790-797. PubMed ID: 32149439
[TBL] [Abstract][Full Text] [Related]
20. Increased nuchal translucency thickness and risk of neurodevelopmental disorders.
Hellmuth SG; Pedersen LH; Miltoft CB; Petersen OB; Kjaergaard S; Ekelund C; Tabor A
Ultrasound Obstet Gynecol; 2017 May; 49(5):592-598. PubMed ID: 27183961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
